Related Experiment Videos

The prevention of pig-bel in Papua New Guinea

Papua and New Guinea Medical Journal
|March 1, 1979
PubMed

Insights

Clostridium welchii type C beta toxoid vaccination significantly reduces pig-bel incidence in Highlands children. This crucial intervention, administered in infancy, offers protection against a leading cause of child mortality.

Area of Science:

  • Medical Microbiology
  • Pediatric Infectious Diseases
  • Vaccinology

Background:

  • Pig-bel, caused by Clostridium welchii type C, is a primary cause of mortality in children over 12 months in the Highlands.
  • Existing health services require enhancement for effective vaccine delivery in the region.

Purpose of the Study:

  • To evaluate the efficacy of Clostridium welchii type C beta toxoid in preventing pig-bel in Highlands children.
  • To provide evidence-based recommendations for infant vaccination schedules.

Main Methods:

  • A double-blind, controlled trial was conducted in Sina Sina.
  • Participants received either Clostridium welchii type C beta toxoid (beta toxoid) or tetanus toxoid as a placebo.
  • Incidence of pig-bel was monitored over a two-year period.

Main Results:

  • A significantly lower incidence of pig-bel was observed in the beta toxoid group (2 cases) compared to the control group (17 cases) (p < 0.02).
  • The study involved 2,538 children receiving beta toxoid and 2,532 receiving tetanus toxoid.

Conclusions:

  • Clostridium welchii type C beta toxoid is an effective prophylactic agent against pig-bel.
  • Recommended infant vaccination schedule: beta toxoid at two, four, and six months of age, with potential need for boosters.
  • Improvement of health services is critical for successful vaccine implementation in the Highlands.

Related Concept Videos